Header Logo

Connection

MICHAEL VOLK to Antineoplastic Agents, Immunological

Back to Details
This is a "connection" page, showing publications MICHAEL VOLK has written about Antineoplastic Agents, Immunological.
MICHAEL VOLK
Connection Strength
0.124
Antineoplastic Agents, Immunological
  1. VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study. Clin Lymphoma Myeloma Leuk. 2018 01; 18(1):e61-e67.
    View in: PubMed
    Score: 0.124
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.